The Family Smoking Prevention and Tobacco Control Act requires the FDA to consult with the Institute of Medicine (IOM) on the design and conduct of studies and surveillance required for the assessment and ongoing review of modified risk tobacco products. Tomorrow, the IOM will release a report on the design and conduct of studies which the FDA will use in the assessment and ongoing review of modified risk tobacco products. Please see below for an invitation from the Institute of Medicine.

The Institute of Medicine report, "Scientific Standards for Studies on Modified Risk Tobacco Products,” will be publicly released at 11:00 AM EST on December 14th, 2011.

This report provides advice to the FDA on the minimum standards for scientific studies to allow the marketing of modified risk tobacco products, and for post-market studies of marketed products, as described in section 911 of the Family Smoking Prevention and Tobacco Control Act of 2009.

More information on the report can be found at: www.iom.edu/modifiedrisktobacco
The IOM will be hosting a teleconference briefing about the report for interested parties. During the briefing, the chair of the committee and several committee members will briefly review the main recommendations and findings of the report, and will also be available to answer questions.

The teleconference will be from 12:00 PM EST to 12:45 PM EST.

Phone Number: 866-528-2256
Access Code: 3343154